KAS
ALNY icon

Kestra Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Kestra Advisory Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Sell
1,184
-667
-36% -$227K ﹤0.01% 2415
2025
Q4 		$736K Buy
1,851
+206
+13% +$91.2K ﹤0.01% 1877
2025
Q3 		$750K Buy
1,645
+561
+52% +$228K ﹤0.01% 1786
2025
Q2 		$353K Buy
1,084
+126
+13% +$34.9K ﹤0.01% 2233
2025
Q1 		$259K Sell
958
-629
-40% -$162K ﹤0.01% 2285
2024
Q4 		$373K Buy
1,587
+284
+22% +$74.7K ﹤0.01% 2074
2024
Q3 		$358K Sell
1,303
-88
-6% -$22.9K ﹤0.01% 1985
2024
Q2 		$338K Buy
1,391
+32
+2% +$5.05K ﹤0.01% 2046
2024
Q1 		$203K Buy
1,359
+91
+7% +$15.2K ﹤0.01% 2271
2023
Q4 		$243K Buy
+1,268
New +$216K ﹤0.01% 1986
2023
Q2 		– Sell
-1,066
Closed -$214K – 2104
2023
Q1 		$214K Sell
1,066
-1,272
-54% -$267K ﹤0.01% 1794
2022
Q4 		$556K Buy
2,338
+721
+45% +$154K ﹤0.01% 1353
2022
Q3 		$324K Buy
1,617
+201
+14% +$38.3K ﹤0.01% 1557
2022
Q2 		$207K Buy
1,416
+77
+6% +$10.9K ﹤0.01% 1876
2022
Q1 		$219K Buy
1,339
+74
+6% +$11.3K ﹤0.01% 1793
2021
Q4 		$215K Sell
1,265
-1,435
-53% -$267K ﹤0.01% 1834
2021
Q3 		$510K Buy
+2,700
New +$506K 0.01% 1379
2020
Q4 		– Sell
-67
Closed -$639K – 1849
2020
Q3 		$639K Buy
+67
New +$9.52K 0.01% 782

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kestra Advisory Services's ALNY Position: Q1 2026 in Review

Kestra Advisory Services reduced its Alnylam Pharmaceuticals (ALNY) stake by 36% in Q1 2026, selling an estimated $227K and leaving 1,184 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

Kestra Advisory Services first reported a position in ALNY in Q3 2020 and has held it in 18 quarters since. The position peaked at $750K in Q3 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Kestra Advisory Services held 1,184 shares of Alnylam Pharmaceuticals worth $392K as of Q1 2026.
  • Kestra Advisory Services sold 667 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $227K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #2415 holding.
  • Kestra Advisory Services first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
  • Kestra Advisory Services's Alnylam Pharmaceuticals position peaked at $750K in Q3 2025.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.